| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-517-31 | 62135-517 | HUMAN PRESCRIPTION DRUG | Allopurinol | Allopurinol | TABLET | ORAL | 20230127 | N/A | ANDA | ANDA077353 | Chartwell RX, LLC | ALLOPURINOL | 300 mg/1 | 300 TABLET in 1 BOTTLE (62135-517-31) |
| 62135-517-90 | 62135-517 | HUMAN PRESCRIPTION DRUG | Allopurinol | Allopurinol | TABLET | ORAL | 20230127 | N/A | ANDA | ANDA077353 | Chartwell RX, LLC | ALLOPURINOL | 300 mg/1 | 90 TABLET in 1 BOTTLE (62135-517-90) |
| 62135-516-31 | 62135-516 | HUMAN PRESCRIPTION DRUG | Allopurinol | Allopurinol | TABLET | ORAL | 20230127 | N/A | ANDA | ANDA077353 | Chartwell RX, LLC | ALLOPURINOL | 100 mg/1 | 300 TABLET in 1 BOTTLE (62135-516-31) |
| 62135-516-90 | 62135-516 | HUMAN PRESCRIPTION DRUG | Allopurinol | Allopurinol | TABLET | ORAL | 20230127 | N/A | ANDA | ANDA077353 | Chartwell RX, LLC | ALLOPURINOL | 100 mg/1 | 90 TABLET in 1 BOTTLE (62135-516-90) |